NeuroSense Therapeutics(NRSN) - Prospectus(update)

As filed with the Securities and Exchange Commission on August 14, 2023. Registration No. 333-273375 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ Amendment No. 1 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NeuroSense Therapeutics Ltd. (Exact Name of Registrant as Specified in Its Charter) ____________________ Not Applicable (Translation of Registrant's name into English) | State of Israel | 2834 | Not Applicable | | --- | --- | --- | | (St ...